Brief: Ryvu Therapeutics Says Company To Receive Development Milestone Of EUR 1 Mln

Ryvu Therapeutics SA

30/12/2021 17:00

Dec 30 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * MENARINI GROUP HAS BEEN GRANTED AN EXCLUSIVE LICENSE TO
DEVELOP
SEL24
    * AS A RESULT, COMPANY IS DUE A DEVELOPMENT MILESTONE IN
AMOUNT OF
EUR 1.0 MILLION

Source text for Eikon:  ID:nEM78CHcka 
Further company coverage:  RVU.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))